HEALTHJun 14 · 02:30 UTCPIX11 NEW YORKMatthew Euzarraga

Popular antidepressant recalled in US over cancer-causing substance fears: FDA

The FDA has initiated a recall of Cymbalta antidepressant by Breckenridge Pharmaceutical due to potential cancer-causing substances. Over 14,000 bottles of Duloxetine delayed-release capsules are being recalled for treating depression, anxiety, and fibromyalgia.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

FDAorganizationBreckenridge Pharmaceutical, Inc.organizationDuloxetine delayed-release capsulesproductCymbaltaproductcancer-causing substancetopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHApr 16 · 04:09 UTC
Anti-anxiety drug Xanax recalled nationwide over fears of dangerous dosing error
HEALTHApr 29 · 11:14 UTC
Urgent warning after recall for batch of antidepressant prescribed to millions: Patients who experience a fast heart beat, nausea, headaches or sleep changes must 'seek medical help immediately'
HEALTHApr 30 · 10:25 UTC
Antidepressant recall chaos: How to know if your prescription contains tablets that could trigger concerning side effects
HEALTHApr 15 · 02:34 UTC
Nail products sold on Amazon urgently recalled over toxic chemicals linked to cancer and organ damage
HEALTHJun 5 · 08:33 UTC
Popular Gas-X medication recalled nationwide due to ‘potential chemical contamination'